News
Ipsen and Marengo Therapeutics announce strategic partnership
A strategic partnership has been announced between Ipsen and Marengo Therapeutics to advance two of Marengo’s preclinical candidates.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
A strategic partnership has been announced between Ipsen and Marengo Therapeutics to advance two of Marengo’s preclinical candidates.